Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Franklin, WI
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Franklin, WI
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tuscaloosa, AL
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Bialystok,
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Bialystok,
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Great Neck, NY
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fargo, ND
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chandler, AZ
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bridgeton, MO
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bridgeton, MO
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Spartanburg, SC
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Renton, WA
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Summerville, SC
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Summerville, SC
Click here to add this to my saved trials
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mesa, AZ
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab Via Autoinjector/Pen vs Healthcare Provider-administered Romosozumab Via Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women
Metabolism and Bone Health
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women
Metabolism and Bone Health
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Fructooligosaccharide and Calcium Absorption in Adolescent Girls
Fructooligosaccharide and Calcium Absorption in Adolescent Girls
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Fructooligosaccharide and Calcium Absorption in Adolescent Girls
Fructooligosaccharide and Calcium Absorption in Adolescent Girls
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Effect of Calcium Supplement Particle Size and Vitamin D Supplement on Calcium Retention in Adolescent Girls
The Effect of Particle Size of Calcium Carbonate and Vitamin D on Calcium and Bone Parameters in Adolescent Girls
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Effect of Calcium Supplement Particle Size and Vitamin D Supplement on Calcium Retention in Adolescent Girls
The Effect of Particle Size of Calcium Carbonate and Vitamin D on Calcium and Bone Parameters in Adolescent Girls
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls
The Effect of Galactooligosaccharide (GOS) Supplementation on Calcium Absorption and Retention in Female Adolescent Girls
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls
The Effect of Galactooligosaccharide (GOS) Supplementation on Calcium Absorption and Retention in Female Adolescent Girls
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Calcium Metabolism in Mexican American Adolescents
Calcium Metabolism in Mexican American Adolescents
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Calcium Metabolism in Mexican American Adolescents
Calcium Metabolism in Mexican American Adolescents
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Effect of Sodium Intake on Calcium Retention in Girls
Effect of Sodium Intake on Calcium Retention in Black and White Adolescent Girls.
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Effect of Sodium Intake on Calcium Retention in Girls
Effect of Sodium Intake on Calcium Retention in Black and White Adolescent Girls.
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Hesperidin and Bone Health in Postmenopausal Women
Hesperidin and Bone Health in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Hesperidin and Bone Health in Postmenopausal Women
Hesperidin and Bone Health in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Alendronate in Juvenile Osteoporosis
Phase II Study of Alendronate Sodium in Juvenile Osteoporosis (IND# 60,017)-Post Study Evaluation of Participants From Phase IIa and Phase IIb Clinical Study.
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Alendronate in Juvenile Osteoporosis
Phase II Study of Alendronate Sodium in Juvenile Osteoporosis (IND# 60,017)-Post Study Evaluation of Participants From Phase IIa and Phase IIb Clinical Study.
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone
Phase I, Open-Label, Pharmacokinetic, Safety and Tolerability Study of Subcutaneously Administered Bisphosphonate With Recombinant Human Hyaluronidase (rHuPH20) vs Bisphosphonate
Status: Enrolling
Updated:  12/31/1969
Healthcare Discoveries, LLC/ICON Development Solutions
mi
from
San Antonio, TX
Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone
Phase I, Open-Label, Pharmacokinetic, Safety and Tolerability Study of Subcutaneously Administered Bisphosphonate With Recombinant Human Hyaluronidase (rHuPH20) vs Bisphosphonate
Status: Enrolling
Updated: 12/31/1969
Healthcare Discoveries, LLC/ICON Development Solutions
mi
from
San Antonio, TX
Click here to add this to my saved trials
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Healthy Children and Adolescent
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Healthy Children and Adolescent
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
Biofortis Innovation Services
mi
from
Addison, IL
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Biofortis Innovation Services
mi
from
Addison, IL
Click here to add this to my saved trials
Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
Prevention of Postmenopausal Bone Loss With Nitric Oxide
Status: Enrolling
Updated:  1/29/2009
UMDNJ-Robert Wood Johnson Medical School, Department of Medicine, Division of Endocrinology
mi
from
New Brunswick, NJ
Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
Prevention of Postmenopausal Bone Loss With Nitric Oxide
Status: Enrolling
Updated: 1/29/2009
UMDNJ-Robert Wood Johnson Medical School, Department of Medicine, Division of Endocrinology
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
Status: Enrolling
Updated:  9/20/2011
University of Missouri-Columbia; McKee Gym
mi
from
Columbia, MO
Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
Status: Enrolling
Updated: 9/20/2011
University of Missouri-Columbia; McKee Gym
mi
from
Columbia, MO
Click here to add this to my saved trials
Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Early Effect of Vitamin D in Primary Hyperparathyroidism
Status: Enrolling
Updated:  10/11/2011
Columbia University Medical Center
mi
from
New York, NY
Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Early Effect of Vitamin D in Primary Hyperparathyroidism
Status: Enrolling
Updated: 10/11/2011
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Selected Non-Malignant Diseases
Status: Enrolling
Updated:  10/18/2011
Columbia University Medical Center
mi
from
New York, NY
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Selected Non-Malignant Diseases
Status: Enrolling
Updated: 10/18/2011
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Status: Enrolling
Updated:  11/23/2011
University of Wisconsin Osteoporosis Clinical Center and Research Program
mi
from
Madison, WI
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Status: Enrolling
Updated: 11/23/2011
University of Wisconsin Osteoporosis Clinical Center and Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency
The Musculoskeletal Response to Energy Deficit: Defining Optimal Protein Intake
Status: Enrolling
Updated:  2/27/2012
USDA Grand Forks Human Nutrition Research Center
mi
from
Grand Forks, ND
Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency
The Musculoskeletal Response to Energy Deficit: Defining Optimal Protein Intake
Status: Enrolling
Updated: 2/27/2012
USDA Grand Forks Human Nutrition Research Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Prevention of Post Operative Bone Loss in Children
Prevention of Post Operative Bone Loss in Children
Status: Enrolling
Updated:  2/29/2012
University of New Mexico Carrie Tingley Hospital
mi
from
Albuquerque, NM
Prevention of Post Operative Bone Loss in Children
Prevention of Post Operative Bone Loss in Children
Status: Enrolling
Updated: 2/29/2012
University of New Mexico Carrie Tingley Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Bone Health in Type 1 Diabetes
Pilot Study - Type 1 Diabetes and Bone Health
Status: Enrolling
Updated:  6/29/2012
Creighton University
mi
from
Omaha, NE
Bone Health in Type 1 Diabetes
Pilot Study - Type 1 Diabetes and Bone Health
Status: Enrolling
Updated: 6/29/2012
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
Status: Enrolling
Updated:  7/26/2012
UCHC
mi
from
Farmington, CT
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
Status: Enrolling
Updated: 7/26/2012
UCHC
mi
from
Farmington, CT
Click here to add this to my saved trials
Role of T-cells in Post-Menopausal Osteoporosis
The Role of T-cells in Women Undergoing Surgical Menopause
Status: Enrolling
Updated:  8/2/2012
Emroy University
mi
from
Atlanta, GA
Role of T-cells in Post-Menopausal Osteoporosis
The Role of T-cells in Women Undergoing Surgical Menopause
Status: Enrolling
Updated: 8/2/2012
Emroy University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Aurora, CO
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Decatur, GA
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  8/30/2012
Clinical Research Facility
mi
from
Baltimore, MD
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 8/30/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Status: Enrolling
Updated:  10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Status: Enrolling
Updated: 10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated:  12/18/2012
Clinical Research Facility
mi
from
Aurora, CO
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated: 12/18/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated:  12/18/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated: 12/18/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated:  12/18/2012
Clinical Research Facility
mi
from
Decatur, GA
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated: 12/18/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated:  12/18/2012
Clinical Research Facility
mi
from
Baltimore, MD
Study to Evaluate the Safety and Efficacy of BA058 for Prevention of Fracture in Postmenopausal Women
A Randomized, Double-blind, Placebo-Controlled, Comparative Multicenter Phase 3 Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women With Severe Osteoporosis and at Risk of Fracture
Status: Enrolling
Updated: 12/18/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessment of Bone Micro-Architecture Using HR-pQCT
Non-Invasive Assessment of Bone Micro-architecture and Strength Changes in Men With Osteopenia and Osteoporosis
Status: Enrolling
Updated:  1/22/2013
UCSF Imaging Center
mi
from
San Francisco, CA
Assessment of Bone Micro-Architecture Using HR-pQCT
Non-Invasive Assessment of Bone Micro-architecture and Strength Changes in Men With Osteopenia and Osteoporosis
Status: Enrolling
Updated: 1/22/2013
UCSF Imaging Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radius Loading in Primary Hyperparathyroidism
Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism
Status: Enrolling
Updated:  2/12/2013
Columbia University Medical Center
mi
from
New York, NY
Radius Loading in Primary Hyperparathyroidism
Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism
Status: Enrolling
Updated: 2/12/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Bone Mineral Density in HIV+ Patients
Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Status: Enrolling
Updated:  4/15/2013
UAB
mi
from
Birmingham, AL
Bone Mineral Density in HIV+ Patients
Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Status: Enrolling
Updated: 4/15/2013
UAB
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Status: Enrolling
Updated:  4/15/2013
UAB
mi
from
Birmingham, AL
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Status: Enrolling
Updated: 4/15/2013
UAB
mi
from
Birmingham, AL
Click here to add this to my saved trials